Home › Funds › Crestline Management, L.P. › SANA
Crestline Management, L.P. position in SANA
SANA BIOTECHNOLOGY INC · Health Care
Crestline Management, L.P. reported holding 755,736 shares of SANA (SANA BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 4.93% of its reported portfolio and ranking #2 among its reported holdings. Crestline Management, L.P. has disclosed SANA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Crestline Management, L.P.'s SANA position evolved
Crestline Management, L.P. first disclosed a stake in SANA in Q3 2023 at 3,365,624 shares (US$13.0M). The position peaked in Q1 2024 at 3,365,624 shares, worth US$33.7M. Across 12 filings, Crestline Management, L.P. increased the stake 0 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 755,736 shares valued at US$2.6M. Notable position changes include a 33% trim in Q4 2025 (shares fell 29% over the following quarter), a 38% trim in Q1 2026 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.37M | $13.02M | New |
| Q4 2023 | 3.37M | $13.73M | Hold |
| Q1 2024 | 3.37M | $33.66M | Hold |
| Q2 2024 | 3.23M | $17.61M | Reduce |
| Q3 2024 | 3.09M | $12.84M | Reduce |
| Q4 2024 | 2.86M | $4.66M | Reduce |
| Q1 2025 | 2.79M | $4.69M | Reduce |
| Q2 2025 | 2.42M | $6.61M | Reduce |
| Q3 2025 | 1.82M | $6.46M | Reduce |
| Q4 2025 | 1.22M | $4.97M | Reduce |
| Q1 2026 | 755.74K | $2.18M | Reduce |
| Q2 2026 | 755.74K | $2.64M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SANA and 13F data
SANA (SANA BIOTECHNOLOGY INC) is a Health Care company. 30 other funds we track also report a position in SANA — the largest reported positions include Flagship Pioneering, LLC (US$87.3M), RA CAPITAL MANAGEMENT, L.P. (US$65.4M), Alphabet Inc. (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SANA
- Flagship Pioneering, LLC 25.00M sh · $87.26M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 18.75M sh · $65.44M · Q2 2026
- Alphabet Inc. 2.81M sh · $9.82M · Q2 2026
More on Crestline Management, L.P.
FAQ
How long has Crestline Management, L.P. held SANA?
Crestline Management, L.P. has disclosed SANA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Crestline Management, L.P.'s current position in SANA?
As of Q2 2026, Crestline Management, L.P. holds 755.74K shares of SANA (SANA BIOTECHNOLOGY INC), valued at $2.64M, representing 4.93% of its reported portfolio and ranking #2.
Has Crestline Management, L.P. been buying or selling SANA?
In the latest 13F filing (Q2 2026), Crestline Management, L.P. held unchanged its position in SANA. The position peaked in Q1 2024 at 3.37M shares.
Which other funds hold SANA?
Other major institutional holders of SANA include Flagship Pioneering, LLC, RA CAPITAL MANAGEMENT, L.P., Alphabet Inc., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.